Navigation Links
Emil Paganini, MD, Joins NxStage(R) as Critical Care Medical Advisor

LAWRENCE, Mass., Feb. 28 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), announced today that Emil Paganini, MD, formerly Section Head of Dialysis and Extracorporeal Therapy with the Cleveland Clinic Foundation, has joined the company as Critical Care Medical Advisor. Dr. Paganini will provide physician leadership for corporate clinical, scientific and educational initiatives to accelerate the company's efforts to transform renal therapies in the critical care environment with innovative yet simple solutions that benefit patients, caregivers and society.

"I am excited that this new role will enable me to continue to work with critical care clinicians, as part of a company that is making significant contributions to our critical care community," said Dr. Paganini. "NxStage is committed to optimizing CRRT's role in improving patient care and is leading the way with innovative support and education for critical care professionals. Jeff Burbank, President and CEO, explained, "We are very excited to add Dr. Paganini to our team. This represents a significant step forward in strengthening our scientific, clinical and educational initiatives. I believe that Dr. Paganini's exceptional track-record as an innovative and dynamic contributor will help us to accelerate our efforts to transform renal therapies in the critical care environment."

Dr. Paganini, MD, FACP, FRCP, was most recently Section Head of Dialysis and Extracorporeal Therapy at the Cleveland Clinic Foundation in Cleveland, Ohio. In addition, Dr. Paganini serves as Chairman of the Ohio Society of Nephrology and Past President of the Health Care Financing Administration Network 9/10. Dr. Paganini is a Coordinating Editor of the International Journal of Artificial Organs and serves on the editorial advisory boards of Seminars in Nephrology, Journal of Nephrology, Journal of Vascular Access, Contemporary Dialysis & Nephrology, and Nephrology News & Issues. He is a member with active participation of: 1) the American College of Physicians and serves on the Reimbursement Subcommittee, 2) the American Medical Association and serves as RUC Nephrology Representative, 3) Renal Physicians Association, and serves as AMA PEAC Advisor, 4) NephStrategies Inc. where he serves as President. He is also a member of the cardio-renal advisory board of the FDA. Dr. Paganini's work has appeared in numerous peer-reviewed journals including Kidney International, Nephrology, Dialysis and Transplant, Journal of the American Society of Nephrology, American Journal of Kidney Disease and Critical Care Medicine.

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company's website at

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including, but not limited to, Dr. Paganini's ability to help us accelerate efforts to transform renal therapies in the critical care environment, and other factors that are discussed in NxStage's filings with the Securities and Exchange Commission, including the Quarterly Report on Form 10-Q for the quarter ended September 30, 2007. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward- looking statements, whether as a result of new information, future events or otherwise.


Jane Hauser

Schwartz Communications


SOURCE NxStage Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Camilo Villegas Joins Vijay Singh in Supporting Eagles for St. Jude Program
2. Nancy Frost Joins Lawson-Hawks as Employee Benefits Vice President
3. Daniel Magilavy, M.D. Joins Rigel as Vice President of Clinical Research
4. Microsoft Joins Forces with SAP America for Healthcare IT
5. Nationally Recognized Information Technology Veteran and Entrepreneur John Bamberger Joins gloStream, Inc. as Chief Channel Officer
6. John OConnell Joins Finesse Solutions as Vice-President of Sales and Business Development
7. Host Jennifer Love Hewitt Joins SBE, The Abbey and Los Angeles Magazine for The Envelope Please, Benefiting AIDS Project Los Angeles
8. True Orange Joins the True Lemon & True Lime Family
9. Secretary Norman Y. Mineta Joins Lung Cancer Alliance Board of Directors
10. Kelli Pedroia, Wife of Red Sox Dustin Pedroia, Joins Melanoma Foundation of New England to Warn About Tanning for the Prom
11. APA Joins With Give an Hour to Help Military Families
Post Your Comments:
(Date:6/27/2016)... ... 2016 , ... The OSHA Training Center at Chabot-Las ... headquartered in Northern California, has issued an important reminder to employers to prevent ... Employers with workers exposed to high temperatures should establish a complete heat illness ...
(Date:6/27/2016)... Viejo, California (PRWEB) , ... June 27, 2016 , ... ... are fully customizable inside of Final Cut Pro X," said Christina Austin - CEO ... another unique style. Final Cut Pro X users can now reveal the ...
(Date:6/27/2016)... ... ... TherapySites, the leading website and online marketing ... Association. This new relationship allows TherapySites to continue to extend their online ... and promotional offers. , "TCA is extremely excited about this new partnership, as ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution ... the emergency ambulance transport experience for the millions of people who require these ... disrupted the taxi industry through the use of technology. Now, SmartEMS has put ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
Breaking Medicine Technology: